20 companies had corporate insiders buying in open-market trades in filings dated Apr 25, 2019, about $29.2 million combined. The biggest was TPTX (Turning Point Therapeutics, Inc.), where Cormorant Asset Management, LP led about $7.2 million of buying.
54 companies had three or more insiders buying in the past 30 days. Six of the buys came from a CEO or CFO. One buy doesn't make a thesis, but it's a good place to start digging.